These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1298067)

  • 1. Immunological studies on some bacterial and parasitic diseases in Thailand.
    Chaicumpa W
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):606-20. PubMed ID: 1298067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New vaccines against bacterial enteric infections.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 70():149-56. PubMed ID: 2287897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serologic possibilities in the diagnosis of tropical diseases from the clinical viewpoint].
    Mohr W
    Med Klin; 1976 Jul; 71():1204-9. PubMed ID: 822267
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial enteric infections and vaccine development.
    Holmgren J; Svennerholm AM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
    Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated oral cholera vaccines.
    Ryan ET; Calderwood SB; Qadri F
    Expert Rev Vaccines; 2006 Aug; 5(4):483-94. PubMed ID: 16989629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
    Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
    Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 76():47-53. PubMed ID: 2102020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 13. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of vibriocidal antibodies to history of cholera vaccination in Thai adult volunteers.
    Pitisuttithum P; Prayurahong B; Migasena S; Suntharasamai P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):219-24. PubMed ID: 2237590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of cholera and rise of novel mucosal vaccine.
    Yamamoto T
    Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia.
    DeRoeck D; Clemens JD; Nyamete A; Mahoney RT
    Vaccine; 2005 Apr; 23(21):2762-74. PubMed ID: 15780724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccines inf the prevention of fecal hazards].
    Saliou P
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against the enterobacteria responsible for enteric infections].
    Sansonetti PJ
    Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Imported infectious diseases].
    Kobari K
    Rinsho Byori; 1979; Spec No():144-53. PubMed ID: 459111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.